Skip to Main Content

Paper Details

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.
EBioMedicine
27
2022
Author NameAffiliation
Mahdad NoursadeghiUniversity College London
  • 1 - 1

Datasets

ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink
ProteomeXchangeProteomics resources portalLink